{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:04:36Z","timestamp":1779379476577,"version":"3.53.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Teaching Hospital Hradec Kr\u00e1lov\u00e9","award":["00179906"],"award-info":[{"award-number":["00179906"]}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"crossref","award":["LM2015089"],"award-info":[{"award-number":["LM2015089"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"crossref","award":["EF16 013\/0001674"],"award-info":[{"award-number":["EF16 013\/0001674"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00428-019-02627-4","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T10:48:58Z","timestamp":1564742938000},"page":"231-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Non-conventional mucosal lesions (serrated epithelial change, villous hypermucinous change) are frequent in patients with inflammatory bowel disease\u2014results of molecular and immunohistochemical single institutional study"],"prefix":"10.1007","volume":"476","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8128-2326","authenticated-orcid":false,"given":"Kate\u0159ina","family":"Kamar\u00e1dov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Vo\u0161mikov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate\u0159ina","family":"Rozko\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ale\u0161","family":"Ry\u0161ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilja","family":"Tachec\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Laco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"issue":"4","key":"2627_CR1","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ibd.20766","volume":"15","author":"T Ullman","year":"2009","unstructured":"Ullman T, Odze R, Farraye FA (2009) Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn\u2019s disease of the colon. Inflamm Bowel Dis 15(4):630\u2013638. \nhttps:\/\/doi.org\/10.1002\/ibd.20766","journal-title":"Inflamm Bowel Dis"},{"issue":"27","key":"2627_CR2","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.3748\/wjg.v17.i27.3184","volume":"17","author":"H Neumann","year":"2011","unstructured":"Neumann H, Vieth M, Langner C, Neurath MF, Mudter J (2011) Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J Gastroenterol 17(27):3184\u20133191. \nhttps:\/\/doi.org\/10.3748\/wjg.v17.i27.3184","journal-title":"World J Gastroenterol"},{"issue":"6","key":"2627_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","volume":"11","author":"F Magro","year":"2017","unstructured":"Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P, Langner C, Limdi JK, Pellino G, Zag\u00f3rowicz E, Raine T, Harbord M, Rieder F, for the European Crohn\u2019s and Colitis Organisation [ECCO] (2017) Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and Ileo-anal pouch disorders. J Crohns Colitis 11(6):649\u2013670. \nhttps:\/\/doi.org\/10.1093\/ecco-jcc\/jjx008","journal-title":"J Crohns Colitis"},{"issue":"1","key":"2627_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","volume":"11","author":"F Gomoll\u00f3n","year":"2017","unstructured":"Gomoll\u00f3n F, Dignass A, Annese V, Tilg H, van Assche G, Lindsay JO, Peyrin-Biroulet L, Cullen GJ, Daperno M, Kucharzik T, Rieder F, Almer S, Armuzzi A, Harbord M, Langhorst J, Sans M, Chowers Y, Fiorino G, Juillerat P, Mantzaris GJ, Rizzello F, Vavricka S, Gionchetti P, on behalf of ECCO (2017) 3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis 11(1):3\u201325. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2015.01.031\n\n. \nhttps:\/\/doi.org\/10.1093\/ecco-jcc\/jjw168","journal-title":"J Crohns Colitis"},{"issue":"10","key":"2627_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.crohns.2013.06.001","volume":"7","author":"F Magro","year":"2013","unstructured":"Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, Villanacci V, Becheanu G, Nunes PB, Cathomas G, Fries W, Jouret-Mourin A, Mescoli C, de Petris G, Rubio CA, Shepherd NA, Vieth M, Eliakim R (2013) European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 7(10):827\u2013851. \nhttps:\/\/doi.org\/10.1016\/j.crohns.2013.06.001","journal-title":"J Crohns Colitis"},{"issue":"3","key":"2627_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1053\/j.gastro.2015.01.031","volume":"81","author":"L Laine","year":"2015","unstructured":"Laine L, Kaltenbach T, Barkun A, McQuaid KR, Subramanian V, Soetikno R et al (2015) SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc 81(3):489\u2013501. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2015.01.031","journal-title":"Gastrointest Endosc"},{"issue":"11","key":"2627_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","volume":"14","author":"RH Riddell","year":"1983","unstructured":"Riddell RH, Goldman H, Ransohoff DF, Appelman AD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC, Sommers SC, Yardley JH (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14(11):931\u2013968. \nhttps:\/\/doi.org\/10.1016\/S0046-8177(83)80175-0","journal-title":"Hum Pathol"},{"issue":"5","key":"2627_CR8","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/gut.45.5.686","volume":"45","author":"SN Andersen","year":"1999","unstructured":"Andersen SN, Lovig T, Clausen OP et al (1999) Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations. Gut 45(5):686\u2013692. \nhttps:\/\/doi.org\/10.1136\/gut.45.5.686","journal-title":"Gut"},{"issue":"7","key":"2627_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/modpathol.3880138","volume":"13","author":"SP Kilgore","year":"2000","unstructured":"Kilgore SP, Sigel JE, Goldblum JR (2000) Hyperplastic-like mucosal change in Crohn\u2019s disease: an unusual form of dysplasia? Mod Pathol 13(7):797\u2013801. \nhttps:\/\/doi.org\/10.1038\/modpathol.3880138","journal-title":"Mod Pathol"},{"issue":"7","key":"2627_CR10","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/j.1440-1746.2007.04944.x","volume":"22","author":"CA Rubio","year":"2007","unstructured":"Rubio CA (2007) Serrated neoplasias and de novo carcinomas in ulcerative colitis: a histological study in colectomy specimens. J Gastroenterol Hepatol 22(7):1024\u20131031. \nhttps:\/\/doi.org\/10.1111\/j.1440-1746.2007.04944.x","journal-title":"J Gastroenterol Hepatol"},{"key":"2627_CR11","doi-asserted-by":"publisher","unstructured":"Bossard C, Denis MG, Bezieau S, Bach-Ngohou K. Bourreille A, Laboisse CL, Mosnier JF (2007) Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis. Oncol Rep 18: 1093\u20131097. \nhttps:\/\/doi.org\/10.3892\/or.18.5.1093","DOI":"10.3892\/or.18.5.1093"},{"issue":"2","key":"2627_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/PAS.0b013e318150d51b","volume":"32","author":"A Srivastava","year":"2008","unstructured":"Srivastava A, Redston M, Farraye FA, Yantiss RK, Odze RD (2008) Hyperplastic\/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity. Am J Surg Pathol 32(2):296\u2013303. \nhttps:\/\/doi.org\/10.1097\/PAS.0b013e318150d51b","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2627_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bpg.2013.03.014","volume":"27","author":"N Harpaz","year":"2013","unstructured":"Harpaz N, Ward SC, Itzkowitz SH MC, Polydorides AD (2013) Precancerous lesions in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 27(2):257\u2013267. \nhttps:\/\/doi.org\/10.1016\/j.bpg.2013.03.014","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"12","key":"2627_CR14","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.3748\/wjg.v20.i12.3164","volume":"20","author":"A Bressenot","year":"2014","unstructured":"Bressenot A, Cahn V, Danese S, Peyrin-Biroulet L (2014) Microscopic features of colorectal neoplasia in inflammatory bowel diseases. World J Gastroenterol 20(12):3164\u20133172. \nhttps:\/\/doi.org\/10.3748\/wjg.v20.i12.3164","journal-title":"World J Gastroenterol"},{"key":"2627_CR15","volume-title":"WHO classification of tumours of the digestive system","year":"2010","unstructured":"Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) (2010) WHO classification of tumours of the digestive system. Lyon, IARC"},{"issue":"12","key":"2627_CR16","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/modpathol.2017.92","volume":"30","author":"Cheng Liu","year":"2017","unstructured":"Liu C, Walker NI, Leggett B, Whitehall V, Bettington ML, Rosty C (2017) Sessile serrated adenomas with dysplasia: morphological patterns and correlations with MLH1 immunohistochemistry. Mod Pathol 2017;30(12):1728\u20131738. \nhttps:\/\/doi.org\/10.1038\/modpathol.2017.92","journal-title":"Modern Pathology"},{"issue":"11","key":"2627_CR17","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gut.2009.194787","volume":"59","author":"M Svrcek","year":"2010","unstructured":"Svrcek M, Buhard O, Colas C, Coulet F, Dumont S, Massaoudi I, Lamri A, Hamelin R, Cosnes J, Oliveira C, Seruca R, Gaub MP, Legrain M, Collura A, Lascols O, Tiret E, Flejou JF, Duval A (2010) Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers. Gut 59(11):1516\u20131526. \nhttps:\/\/doi.org\/10.1136\/gut.2009.194787","journal-title":"Gut"},{"issue":"7","key":"2627_CR18","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/annonc\/mdn782","volume":"20","author":"S. de Vogel","year":"2009","unstructured":"de Vogel S, Weijenberg MP, Herman JG, Wouters KA, de Goeij AF, van den Brandt PA, de Bru\u00efne, AP van Engeland M (2009) MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events. Ann Oncol 20:1216\u20131222. \nhttps:\/\/doi.org\/10.1093\/annonc\/mdn782","journal-title":"Annals of Oncology"},{"issue":"5","key":"2627_CR19","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.7314\/APJCP.2015.16.5.1945","volume":"16","author":"P Mokarram","year":"2015","unstructured":"Mokarram P, Kavousipour S, Sarabi MM, Mehrabani G, Fahmidehkar MA, Shamsdin SA, Alipour A, Naini MA (2015) MGMT-B gene promoter hypermethylation in patients with inflammatory bowel disease - a novel finding. Asian Pac J Cancer Prev 16(5):1945\u20131952. \nhttps:\/\/doi.org\/10.7314\/APJCP.2015.16.5.1945","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"2627_CR20","doi-asserted-by":"publisher","first-page":"S11 Abstract 42","DOI":"10.1016\/S0016-5085(13)60038-4","volume":"144","author":"AM Parian","year":"2013","unstructured":"Parian AM, Koh JM, Badamas J, Ciardello FM, Montgomery E, Lazerev M (2013) Serrated epithelial changes are associated with colorectal dysplasia in inflammatory bowel disease. Gastroenterology 144(5):S11 Abstract 42. \nhttps:\/\/doi.org\/10.1016\/S0016-5085(13)60038-4","journal-title":"Gastroenterology"},{"issue":"4","key":"2627_CR21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.prp.2019.01.010","volume":"215","author":"K Kamaradova","year":"2019","unstructured":"Kamaradova K, Vosmikova H, Rozkosova K, Tacheci I, Ryska A, Laco J (2019) Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions \u2013 single institution experience. Path Res Pract 215(4):730\u2013737. \nhttps:\/\/doi.org\/10.1016\/j.prp.2019.01.010","journal-title":"Path Res Pract"},{"key":"2627_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/BF02555626","volume":"27","author":"CA Rubio","year":"1984","unstructured":"Rubio CA, Johansson C, Slezak P, Ohman U, Hammarberg C (1984) Villous dysplasia: an ominous histologic sign in colitis patients. Dis Colon Rectum 27:283\u2013287022","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"2627_CR23","first-page":"767","volume":"144","author":"P Chaubert","year":"1994","unstructured":"Chaubert P, Benhattar J, Saraga E, Costa J (1994) K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 144(4):767\u2013775","journal-title":"Am J Pathol"},{"issue":"6C","key":"2627_CR24","first-page":"4761","volume":"20","author":"CA Rubio","year":"2000","unstructured":"Rubio CA, Befrits R, Jaramillo E, Nesi G, Amorosi A (2000) Villous and serrated adenomatous growth bordering carcinomas in inflammatory bowel disease. Anticancer Res 20(6C):4761\u20134764","journal-title":"Anticancer Res"},{"issue":"Suppl","key":"2627_CR25","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1111\/j.1443-1661.2005.00517.x","volume":"17","author":"N Hamamoto","year":"2005","unstructured":"Hamamoto N, Rubio CA, Befrits R, Toyoda H, Ceballos J, Jaramillo E (2005) Subtle villous changes in IBD patients. Dig Endosc 17(Suppl):S34\u2013S39","journal-title":"Dig Endosc"},{"issue":"1","key":"2627_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gie.2015.12.010","volume":"84","author":"A Parian","year":"2016","unstructured":"Parian A, Koh J, Limketkai BN, Eluri S, Rubin DT, Brant SR, Ha CY, Bayless TM, Giardiello F, Hart J, Montgomery E, Lazarev MG (2016) Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointest Endosc 84(1):87\u201395. \nhttps:\/\/doi.org\/10.1016\/j.gie.2015.12.010","journal-title":"Gastrointest Endosc"},{"issue":"12","key":"2627_CR27","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/apt.12774","volume":"39","author":"DH Johnson","year":"2014","unstructured":"Johnson DH, Khanna S, Smyrk TC, Loftus EV Jr, Anderson KS, Mahoney DW, Ahlquist DA, Kisiel JB (2014) Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn\u2019s colitis. Aliment Pharmacol Ther 39(12):1408\u20131417. \nhttps:\/\/doi.org\/10.1111\/apt.12774","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"2627_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1155\/2014\/386540","volume":"28","author":"M Iacucci","year":"2014","unstructured":"Iacucci M, Hassan C, Fort Gasia M, Urbanski S, Gui X, Eksteen B, Eustace G, Kaplan GG, Panaccione R (2014) Serrated adenoma prevalence in inflammatory bowel disease surveillance colonoscopy, and characteristics revealed by chromoendoscopy and virtual chromoendoscopy. Can J Gastroenterol Hepatol 28(11):589\u2013594","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"10","key":"2627_CR29","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.humpath.2015.06.019","volume":"46","author":"J Shen","year":"2015","unstructured":"Shen J, Gibson JA, Schulte S, Khurana H, Farraye FA, Levine J, Burakoff R, Cerda S, Qazi T, Hamilton M, Srivastava A, Odze RD (2015) Clinical, pathologic, and outcome study of hyperplastic and sessile serrated polyps in inflammatory bowel disease. Hum Pathol 46(10):1548\u20131556. \nhttps:\/\/doi.org\/10.1016\/j.humpath.2015.06.019","journal-title":"Hum Pathol"},{"issue":"12","key":"2627_CR30","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/modpathol.2015.111","volume":"28","author":"HM Ko","year":"2015","unstructured":"Ko HM, Harpaz N, McBride RB, Cui M, Ye F, Zhang D, Ullman TA, Polydorides AD (2015) Serrated colorectal polyps in inflammatory bowel disease. Mod Pathol 28(12):1584\u20131593. \nhttps:\/\/doi.org\/10.1038\/modpathol.2015.111","journal-title":"Mod Pathol"},{"key":"2627_CR31","doi-asserted-by":"publisher","first-page":"5490803","DOI":"10.1155\/2017\/5490803","volume":"2017","author":"LH Lee","year":"2017","unstructured":"Lee LH, Iacucci M, Fort Gasia M, Ghosh S, Panaccione R, Urbanski S (2017) Prevalence and anatomic distribution of serrated and adenomatous lesions in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol 2017:5490803. Published online 2017 Jan 15. \nhttps:\/\/doi.org\/10.1155\/2017\/5490803","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"1","key":"2627_CR32","first-page":"19","volume":"14","author":"AM Parian","year":"2018","unstructured":"Parian AM, Lazarev MG (2018) Serrated colorectal lesions in patients with inflammatory bowel disease. Gastroenterol Hepatol 14(1):19\u201325","journal-title":"Gastroenterol Hepatol"},{"issue":"12","key":"2627_CR33","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.crohns.2014.07.001","volume":"8","author":"JD Feuerstein","year":"2014","unstructured":"Feuerstein JD, Flier SN, Yee EU, Pleskow D, Cheifetz AS (2014) A rare case series of concomitant inflammatory bowel disease, sporadic adenomas, and serrated polyposis syndrome. J Crohns Colitis 8(12):1735\u20131739. \nhttps:\/\/doi.org\/10.1016\/j.crohns.2014.07.001","journal-title":"J Crohns Colitis"},{"issue":"5","key":"2627_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.14740\/gr1064w","volume":"11","author":"C Yang","year":"2018","unstructured":"Yang C, Tarabishy Y, Dassopoulos T, Nalbantoglu I (2018) Clinical, histologic, and immunophenotypic features of serrated polyps in patients with inflammatory bowel disease. Gastroenterol Res 11(5):355\u2013360. \nhttps:\/\/doi.org\/10.14740\/gr1064w","journal-title":"Gastroenterol Res"},{"issue":"20","key":"2627_CR35","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1158\/1078-0432.CCR-18-0630","volume":"24","author":"D Hirsch","year":"2018","unstructured":"Hirsch D, Wangsa D, Zhu YJ, Hu Y, Edelman DC, Meltzer PS, Heselmeyer-Haddad K, Ott C, Kienle P, Galata C, Horisberger K, Ried T, Gaiser T (2018) Dynamics of genome alterations in Crohn\u2019s disease associated colorectal carcinogenesis. Clin Cancer Res 24(20):4997\u20135011. \nhttps:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0630","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2627_CR36","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s10620-015-3646-4","volume":"60","author":"M Yashiro","year":"2015","unstructured":"Yashiro M (2015) Molecular alterations of colorectal cancer with inflammatory bowel disease. Dig Dis Sci 60(8):2251\u20132263. \nhttps:\/\/doi.org\/10.1007\/s10620-015-3646-4","journal-title":"Dig Dis Sci"},{"issue":"4","key":"2627_CR37","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1053\/j.gastro.2015.12.036","volume":"150","author":"AI Robles","year":"2016","unstructured":"Robles AI, Traverso G, Zhang M, Roberts NJ, Khan MA, Joseph C, Lauwers GY, Selaru FM, Popoli M, Pittman ME, Ke X, Hruban RH, Meltzer SJ, Kinzler KW, Vogelstein B, Harris CC, Papadopoulos N (2016) Whole-exome sequencing analyses of inflammatory bowel disease-associated colorectal cancers. Gastroenterology 150(4):931\u2013943. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2015.12.036","journal-title":"Gastroenterology"},{"issue":"4","key":"2627_CR38","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.dld.2016.12.011","volume":"49","author":"D Saraggi","year":"2017","unstructured":"Saraggi D, Fassan M, Mescoli C, Scarpa M, Valeri N, Michielan A, D'Inc\u00e1 R, Rugge M (2017) The molecular landscape of colitis-associated carcinogenesis. Dig Liver Dis 49(4):326\u2013330. \nhttps:\/\/doi.org\/10.1016\/j.dld.2016.12.011","journal-title":"Dig Liver Dis"},{"issue":"13","key":"2627_CR39","doi-asserted-by":"publisher","first-page":"22175","DOI":"10.18632\/oncotarget.14549","volume":"8","author":"L Du","year":"2017","unstructured":"Du L, Kim JJ, Shen J, Chen B, Dai N (2017) KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis. Oncotarget 8(13):22175\u201322186. \nhttps:\/\/doi.org\/10.18632\/oncotarget.14549","journal-title":"Oncotarget"},{"issue":"4","key":"2627_CR40","doi-asserted-by":"publisher","first-page":"320","DOI":"10.7150\/jca.3619","volume":"4","author":"IH Sahin","year":"2013","unstructured":"Sahin IH, Kazmi SM, Yorio JT, Bhadkamkar NA, Kee BK, Garrett CR (2013) Rare though not mutually exclusive: a report of three cases of concomitant KRAS and BRAF mutation and a review of the literature. J Cancer 4(4):320\u2013322. \nhttps:\/\/doi.org\/10.7150\/jca.3619","journal-title":"J Cancer"},{"issue":"Suppl 1","key":"2627_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.22074\/cellj.2017.5123","volume":"19","author":"P Larki","year":"2017","unstructured":"Larki P, Gharib E, Yaghoob Taleghani M, Khorshidi F, Nazemalhosseini-Mojarad E, Asadzadeh Aghdaei H (2017) Coexistence of KRAS and BRAF mutations in colorectal cancer: a case report supporting the concept of tumoral heterogeneity. Cell J 19(Suppl 1):113\u2013117. \nhttps:\/\/doi.org\/10.22074\/cellj.2017.5123","journal-title":"Cell J"},{"issue":"15","key":"2627_CR42","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1200\/JCO.2010.33.5091","volume":"29","author":"E Van Cutsem","year":"2011","unstructured":"Van Cutsem E, K\u00f6hne CH, L\u00e1ng I, Folprecht G, Nowacki MP, Cascinu S, Shchepotin I, Maurel J, Cunningham D, Tejpar S, Schlichting M, Zubel A, Celik I, Rougier P, Ciardiello F (2011) Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol 29(15):2011\u20132019. \nhttps:\/\/doi.org\/10.1200\/JCO.2010.33.5091","journal-title":"J Clin Oncol"},{"issue":"4","key":"2627_CR43","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4103\/1319-3767.56102","volume":"15","author":"AS Sameer","year":"2009","unstructured":"Sameer AS, ul Rehman S, Pandith AA, Syeed N, Shah ZA, Chowdhri NA, Wani KA, Siddiqi MA (2009) Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area. Saudi J Gastroenterol 15(4):244\u2013252. \nhttps:\/\/doi.org\/10.4103\/1319-3767.56102","journal-title":"Saudi J Gastroenterol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02627-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-019-02627-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02627-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T08:37:32Z","timestamp":1596271052000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-019-02627-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2627"],"URL":"https:\/\/doi.org\/10.1007\/s00428-019-02627-4","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,2]]},"assertion":[{"value":"1 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Retrospective study not subjected to approval by local ethical committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}